These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16915281)

  • 1. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
    Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
    Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.
    Land SC; Tee AR
    J Biol Chem; 2007 Jul; 282(28):20534-43. PubMed ID: 17502379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic PML function in TGF-beta signalling.
    Lin HK; Bergmann S; Pandolfi PP
    Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
    Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O
    Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheb binds and regulates the mTOR kinase.
    Long X; Lin Y; Ortiz-Vega S; Yonezawa K; Avruch J
    Curr Biol; 2005 Apr; 15(8):702-13. PubMed ID: 15854902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
    Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH
    Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a tumour suppressor network opposing nuclear Akt function.
    Trotman LC; Alimonti A; Scaglioni PP; Koutcher JA; Cordon-Cardo C; Pandolfi PP
    Nature; 2006 May; 441(7092):523-7. PubMed ID: 16680151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
    Li W; Petrimpol M; Molle KD; Hall MN; Battegay EJ; Humar R
    Circ Res; 2007 Jan; 100(1):79-87. PubMed ID: 17110594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.
    Castro AF; Rebhun JF; Clark GJ; Quilliam LA
    J Biol Chem; 2003 Aug; 278(35):32493-6. PubMed ID: 12842888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pml represses tumour progression through inhibition of mTOR.
    Bernardi R; Papa A; Egia A; Coltella N; Teruya-Feldstein J; Signoretti S; Pandolfi PP
    EMBO Mol Med; 2011 May; 3(5):249-57. PubMed ID: 21387562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.
    Scaglioni PP; Rabellino A; Yung TM; Bernardi R; Choi S; Konstantinidou G; Nardella C; Cheng K; Pandolfi PP
    EMBO Mol Med; 2012 Jul; 4(7):594-602. PubMed ID: 22359342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of mTOR and cell growth in response to energy stress by REDD1.
    Sofer A; Lei K; Johannessen CM; Ellisen LW
    Mol Cell Biol; 2005 Jul; 25(14):5834-45. PubMed ID: 15988001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
    Fleischer S; Wiemann S; Will H; Hofmann TG
    Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced energy stress regulates mRNA translation and cell growth.
    Liu L; Cash TP; Jones RG; Keith B; Thompson CB; Simon MC
    Mol Cell; 2006 Feb; 21(4):521-31. PubMed ID: 16483933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants.
    Fang W; Mori T; Cobrinik D
    Oncogene; 2002 Aug; 21(36):5557-65. PubMed ID: 12165854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.